Literature DB >> 9587122

Selective expression of inducible nitric oxide synthase in human prostate carcinoma.

T Klotz1, W Bloch, C Volberg, U Engelmann, K Addicks.   

Abstract

BACKGROUND: Nitric oxide (NO) is synthesized by inducible nitric oxide synthase (iNOS) and plays an important role in tumor growth and angiogenesis. NO generation by iNOS also influences the cytotoxicity of macrophages and tumor-induced immunosuppression. Before now, the expression of iNOS in prostate carcinoma tissue had not been determined.
METHODS: In this study, tissue sections from 16 patients with prostate carcinoma were studied immunohistochemically and compared with tissue specimens from 10 patients with benign hyperplasia.
RESULTS: Positive iNOS immunostaining was detected in all sections from patients with prostate carcinoma. The malignant epithelial cells were highly positive. The antibody against iNOS also marked round cells, which had the same cell shape as that observed for macrophages. These cells were located in stroma and epithelium adjacent to tumor islets. However, round cells in benign tissue stained negative for iNOS. None of the benign hyperplasia specimens stained positive for iNOS immunohistochemically.
CONCLUSIONS: Prostate carcinoma tissue had a high iNOS content, whereas benign tissue did not. The authors suggest that epithelial iNOS expression can be used as a specific immunohistochemical marker for prostate carcinoma. NO generation by iNOS may play multiple roles in the development of this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9587122

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  53 in total

1.  Nitrative and oxidative DNA damage as potential survival biomarkers for nasopharyngeal carcinoma.

Authors:  Yuan-Jiao Huang; Bei-Bei Zhang; Ning Ma; Mariko Murata; An-Zhou Tang; Guang-Wu Huang
Journal:  Med Oncol       Date:  2010-03-26       Impact factor: 3.064

2.  Effect of a nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on invasion of human colorectal cancer cell line SL-174T.

Authors:  Li-Bo Yu; Xin-Shu Dong; Wen-Zhou Sun; Dong-Lu Zhao; Yue Yang
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

3.  Quantitative immunohistochemical detection of the molecular expression patterns in proliferative inflammatory atrophy.

Authors:  M Karaivanov; K Todorova; A Kuzmanov; S Hayrabedyan
Journal:  J Mol Histol       Date:  2006-12-15       Impact factor: 2.611

4.  The apoptotic inducible effects of salicylic acid on hepatoma cell line: relationship with nitric oxide signaling.

Authors:  Yahui Liu; Yong Wang; Yue Hu; Shuxiong Ge; Keshi Li; Shuangshuang Wang; Li Li
Journal:  J Cell Commun Signal       Date:  2017-02-09       Impact factor: 5.782

5.  Long-term adaptation of breast tumor cell lines to high concentrations of nitric oxide.

Authors:  Benjamin J Vesper; Kim M Elseth; Gabor Tarjan; G Kenneth Haines; James A Radosevich
Journal:  Tumour Biol       Date:  2010-05-18

Review 6.  Nitric oxide and angiogenesis.

Authors:  M Ziche; L Morbidelli
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 7.  The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Authors:  Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2018-02-14       Impact factor: 5.858

Review 8.  iNOS expression in oral and gastrointestinal tract mucosa.

Authors:  Nurullah Keklikoglu; Meltem Koray; Humeyra Kocaelli; Sevtap Akinci
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

9.  Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis.

Authors:  Zhen Lin; Shiping Chen; Chuanzhong Ye; Shaoxing Zhu
Journal:  Urol Res       Date:  2003-02-27

10.  Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers.

Authors:  L Morbidelli; S Donnini; S Filippi; L Messori; F Piccioli; P Orioli; G Sava; M Ziche
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.